Brokerage View Tracker Key Calls and Target Changes
Citi on Info Edge maintained Sell with a revised target of Rs.1120 cut from Rs.1300. While 3Q EBITDA beat estimates by 10 percent and recruitment revenues surprised positively, the brokerage cut FY27 and FY28 EPS by 14 percent and 9 percent citing slower hiring outlook and AI overhang. Valuation multiple was sharply reduced to 13x Sep27E EV EBITDA from 20x earlier.
Motilal Oswal on Petronet LNG retained Buy with target of Rs.365. 3QFY26 EBITDA came 7 percent above estimates with stable performance. Capacity tie ups and volume recovery remain key triggers. At 10.3x FY27E P E with about 3.7 percent dividend yield the stock appears inexpensive.
Motilal Oswal on Eris Lifesciences maintained Neutral with target of Rs.1520 after the company reported a miss across metrics. Revenue EBITDA and PAT fell short by 4 percent 8 percent and 11 percent respectively. FY26 to FY28 earnings estimates were trimmed by 5 percent to 7 percent.
Motilal Oswal on Inox Wind kept Buy with target of Rs.150. The quarter remained soft due to delivery disappointment though management commentary and order outlook stayed positive. FY26 and FY27 PAT estimates were cut by 10 percent and 5 percent.
Motilal Oswal on Vedant Fashions retained Neutral with target reduced to Rs.510 from Rs.600. Fewer wedding days impacted performance leading to 4 percent YoY revenue decline. Earnings estimates for FY26 and FY27 were cut by about 8 to 9 percent.
Motilal Oswal on Senco Gold maintained Neutral with target of Rs.375. Profitability beat expectations but volumes remained volatile. Gold volumes fell while diamond segment showed healthy growth. EPS for FY27 was raised by 12 percent.
Motilal Oswal on Mrs Bector Foods upgraded the stock to Buy with target of Rs.270. Margin improved sequentially and the firm expects about 13 percent revenue CAGR over FY25 to FY28 driven by domestic bakery strength and premiumisation.
Kotak Securities on Ola Electric recommended Sell with target of Rs.20 citing weak results and lack of volume pickup. The brokerage warned of potential net losses and balance sheet stress over FY26 to FY28.
Citi on Indus Towers reiterated Buy with target of Rs.540. Key near term catalysts include Voda Idea debt closure AGR reassessment and possible reinstatement of shareholder payouts. Bharti’s open market buying is seen as positive.
Citi and Jefferies on GMR Airports remained positive. Citi kept Buy with target Rs.109 noting sharp turnaround in core profit and strong non aero growth. Jefferies also maintained Buy with higher target of Rs.125 highlighting EBITDA surge and improving profitability visibility.
Jefferies and CLSA on ONGC stayed constructive. Jefferies Buy target Rs.325 expects production CAGR of 5 percent. CLSA high conviction outperform target Rs.315 sees over 15 percent domestic gas output rise ahead with dividend payout nearing multi year high.
HSBC and Jefferies on Biocon had mixed views. HSBC maintained Buy with target Rs.445 citing biosimilar outlook intact. Jefferies kept Hold with target Rs.360 after margin pressure and modest growth.
Jefferies and HSBC on PI Industries remained cautious. Jefferies Buy target Rs.3675 expects recovery ahead though near term weakness persists. HSBC Hold target Rs.3200 flagged margin disappointment and execution uncertainty.
Jefferies and HSBC on Marico stayed positive with Buy and target Rs.900 each. Recent acquisitions are expected to fill portfolio gaps and drive premiumisation with strong growth ambition by FY30.
CLSA and Jefferies on IGL offered mixed stance. CLSA Outperform target Rs.240 expects margin improvement while Jefferies Buy target Rs.215 sees growth recovery from FY27 onward.
JPMorgan on Blue Jet Healthcare downgraded to Underweight with target cut to Rs.330 citing weak execution in contrast media business product concentration risk and pipeline concerns.
Leave A Comment